Bukwang Pharmaceutical Co., Ltd. (KRX:003000)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,640.00
+125.00 (3.56%)
At close: Oct 2, 2025

Bukwang Pharmaceutical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
8,360-2,641-31,330-2,475-916.62-7,203
Upgrade
Depreciation & Amortization
4,7194,1064,2925,1174,8436,158
Upgrade
Loss (Gain) From Sale of Assets
-379.89-53.75-30.64-52.25-220.05-54.25
Upgrade
Asset Writedown & Restructuring Costs
4,9279,585---3,539
Upgrade
Loss (Gain) From Sale of Investments
4,449-738.9564.4567.47-90.533,297
Upgrade
Loss (Gain) on Equity Investments
858.34-343.131,501-58.571,3612,838
Upgrade
Stock-Based Compensation
-3.53-3.53147.4944.333.413,226
Upgrade
Provision & Write-off of Bad Debts
-145.64-554.54-4,8972,9021,6941,264
Upgrade
Other Operating Activities
6,416379.98-3,3733,261917.18-3,028
Upgrade
Change in Accounts Receivable
1,32412,93357,117-423.7411,5546,663
Upgrade
Change in Inventory
2,05014,296-18,388208.4312,182-7,814
Upgrade
Change in Accounts Payable
8,3902,432-14,1609,154-2,735-1,102
Upgrade
Change in Other Net Operating Assets
-3,095-5,035-806.65-1,782-2,066-7,060
Upgrade
Operating Cash Flow
37,87034,362-9,36216,46126,525723.17
Upgrade
Operating Cash Flow Growth
74.19%---37.94%3567.88%-
Upgrade
Capital Expenditures
-5,059-1,938-2,835-4,298-785.05-1,917
Upgrade
Sale of Property, Plant & Equipment
815.945.52142.271.27388.4518,215
Upgrade
Divestitures
-11,552369.75238.89---
Upgrade
Sale (Purchase) of Intangibles
-3,808-629.25267.3-692.11-4.47-36.93
Upgrade
Investment in Securities
-47,580-25,575-152.851,5885,150-3,213
Upgrade
Other Investing Activities
0020180-00
Upgrade
Investing Cash Flow
-67,183-27,727-2,319-3,1514,74913,048
Upgrade
Short-Term Debt Issued
-10,000-10,000-96,300
Upgrade
Long-Term Debt Issued
--80,000---
Upgrade
Total Debt Issued
-10,00080,00010,000-96,300
Upgrade
Short-Term Debt Repaid
--10,000--10,000-20,000-76,300
Upgrade
Long-Term Debt Repaid
--63,602-447.86-433.92-452.42-443.28
Upgrade
Total Debt Repaid
-358.64-73,602-447.86-10,434-20,452-76,743
Upgrade
Net Debt Issued (Repaid)
-358.64-63,60279,552-433.92-20,45219,557
Upgrade
Issuance of Common Stock
---100--
Upgrade
Repurchase of Common Stock
-----516.19-25,112
Upgrade
Dividends Paid
----6,845-6,225-12,190
Upgrade
Other Financing Activities
-3,754-4,049-2,714-469.66-290.9445,978
Upgrade
Financing Cash Flow
-4,112-67,65176,839-10,398-27,48528,232
Upgrade
Foreign Exchange Rate Adjustments
777.35-120.02552.82-172.98-303.37-297.75
Upgrade
Net Cash Flow
-32,648-61,13665,7102,7403,48641,706
Upgrade
Free Cash Flow
32,81132,424-12,19612,16325,740-1,194
Upgrade
Free Cash Flow Growth
62.04%---52.74%--
Upgrade
Free Cash Flow Margin
18.31%20.25%-9.69%6.37%14.11%-0.70%
Upgrade
Free Cash Flow Per Share
478.73473.65-178.17177.69375.98-17.40
Upgrade
Cash Interest Paid
3,7364,0321,139147.12290.94947.14
Upgrade
Cash Income Tax Paid
-1,588900.44,1168,9339,093
Upgrade
Levered Free Cash Flow
10,796-34,26259,1499,28525,2411,316
Upgrade
Unlevered Free Cash Flow
14,852-30,20661,52910,38526,1212,263
Upgrade
Change in Working Capital
8,66924,62623,7637,15618,934-9,313
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.